286 related articles for article (PubMed ID: 12734353)
1. TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms.
Brown GR; Lee EL; Thiele DL
J Immunol; 2003 May; 170(10):5082-8. PubMed ID: 12734353
[TBL] [Abstract][Full Text] [Related]
2. TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice.
Brown GR; Lee E; Thiele DL
J Immunol; 2002 Mar; 168(6):3065-71. PubMed ID: 11884480
[TBL] [Abstract][Full Text] [Related]
3. IL-12-independent LIGHT signaling enhances MHC class II disparate CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease.
Brown GR; Lee EL; El-Hayek J; Kintner K; Luck C
J Immunol; 2005 Apr; 174(8):4688-95. PubMed ID: 15814693
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of MHC class I-stimulated alloresponses by TNF/TNF receptor (TNFR)1 interactions and of MHC class II-stimulated alloresponses by TNF/TNFR2 interactions.
Brown GR; Thiele DL
Eur J Immunol; 2000 Oct; 30(10):2900-7. PubMed ID: 11069072
[TBL] [Abstract][Full Text] [Related]
5. The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD.
El-Hayek JM; Rogers TE; Brown GR
J Leukoc Biol; 2005 Oct; 78(4):1001-7. PubMed ID: 16081594
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor is critical for cytolytic T cell activity against allospecific hepatocytes and splenic targets in major histocompatibility complex class I disparate graft versus host disease.
Ali S; Starwalt R; Kreck J; Whittington B; Brown GR
J Interferon Cytokine Res; 2011 May; 31(5):423-31. PubMed ID: 21091241
[TBL] [Abstract][Full Text] [Related]
7. T-cell activation and differentiation are regulated by TNF during murine DBA/2-->B6D2F1 intestinal graft-versus-host disease.
Brown GR; Thiele DL
J Clin Immunol; 2000 Sep; 20(5):379-88. PubMed ID: 11051280
[TBL] [Abstract][Full Text] [Related]
8. CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-host-disease.
Rao AR; Quinones MP; Garavito E; Kalkonde Y; Jimenez F; Gibbons C; Perez J; Melby P; Kuziel W; Reddick RL; Ahuja SK; Ahuja SS
J Immunol; 2003 Nov; 171(9):4875-85. PubMed ID: 14568968
[TBL] [Abstract][Full Text] [Related]
9. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
Krenger W; Snyder KM; Byon JC; Falzarano G; Ferrara JL
J Immunol; 1995 Jul; 155(2):585-93. PubMed ID: 7608537
[TBL] [Abstract][Full Text] [Related]
10. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ
J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044
[TBL] [Abstract][Full Text] [Related]
11. The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity.
Hill GR; Teshima T; Rebel VI; Krijanovski OI; Cooke KR; Brinson YS; Ferrara JL
J Immunol; 2000 Jan; 164(2):656-63. PubMed ID: 10623807
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.
Yang YG; Sergio JJ; Pearson DA; Szot GL; Shimizu A; Sykes M
Blood; 1997 Dec; 90(11):4651-60. PubMed ID: 9373279
[TBL] [Abstract][Full Text] [Related]
13. Suppression of allograft responses induced by interleukin-6, which selectively modulates interferon-gamma but not interleukin-2 production.
Tomura M; Nakatani I; Murachi M; Tai XG; Toyo-oka K; Fujiwara H
Transplantation; 1997 Sep; 64(5):757-63. PubMed ID: 9311716
[TBL] [Abstract][Full Text] [Related]
14. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.
Blazar BR; Lees CJ; Martin PJ; Noelle RJ; Kwon B; Murphy W; Taylor PA
J Immunol; 2000 Nov; 165(9):4901-9. PubMed ID: 11046015
[TBL] [Abstract][Full Text] [Related]
15. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
Berger M; Wettstein PJ; Korngold R
Transplantation; 1994 Apr; 57(7):1095-102. PubMed ID: 7909395
[TBL] [Abstract][Full Text] [Related]
16. CP-690550, a Janus kinase inhibitor, suppresses CD4+ T-cell-mediated acute graft-versus-host disease by inhibiting the interferon-γ pathway.
Park HB; Oh K; Garmaa N; Seo MW; Byoun OJ; Lee HY; Lee DS
Transplantation; 2010 Oct; 90(8):825-35. PubMed ID: 20697326
[TBL] [Abstract][Full Text] [Related]
17. Increased entry into the IFN-gamma effector pathway by CD4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic background.
Koarada S; Wu Y; Ridgway WM
J Immunol; 2001 Aug; 167(3):1693-702. PubMed ID: 11466393
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
[TBL] [Abstract][Full Text] [Related]
19. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
Rolink AG; Pals ST; Gleichmann E
J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12.
Becher B; Blain M; Giacomini PS; Antel JP
J Immunol; 1999 Jan; 162(2):684-8. PubMed ID: 9916686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
